Funding round
Adjuvia Therapeutics raises $8M seed round
Adjuvia Therapeutics (USA) has raised $8M in a seed round, announced on July 29, 2026. The company is Develops novel mitochondrial disease therapies for clinical trials.
Adjuvia Therapeutics closed $8 million Series Seed financing to advance ATI-105, a mitochondrial disease therapy, into Phase 1 clinical trials.
Company
Adjuvia Therapeutics
Amount
$8M (~$8M)
Round
Seed
Sector
Biotech/Therapeutics
Country
USA
Announced
July 29, 2026
Track every raise, every day
This deal appeared in The Daily Raise, July 29, 2026. Get the next edition in your inbox.
Just raised too?
Turn your funding news into guaranteed media coverage while the momentum lasts.